Marta Santisteban

2.2k total citations · 1 hit paper
55 papers, 957 citations indexed

About

Marta Santisteban is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marta Santisteban has authored 55 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 12 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marta Santisteban's work include Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (9 papers) and Cancer Treatment and Pharmacology (9 papers). Marta Santisteban is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (9 papers) and Cancer Treatment and Pharmacology (9 papers). Marta Santisteban collaborates with scholars based in Spain, United States and Belgium. Marta Santisteban's co-authors include Lynn C. Hartmann, Aziza Nassar, Derek C. Radisky, Michael K. Asiedu, Masoud H. Manjili, Keith L. Knutson, Marshall D. Behrens, Paul Haluska, Soldano Ferrone and Jennifer M. Reiman and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Marta Santisteban

51 papers receiving 944 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dendritic Cells in Cancer Immunology and Immunotherapy

2024 62 citations José Luis Perez‐Gracia, Javier Rodríguez et al. Cancers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marta Santisteban Spain	16	582	308	264	161	134	55	957
Hidekatsu Nakai Japan	21	445 0.8×	323 1.0×	194 0.7×	207 1.3×	96 0.7×	75	1.3k
Salvatore Lopez Italy	25	551 0.9×	369 1.2×	183 0.7×	195 1.2×	213 1.6×	89	1.6k
Jan Kornafel Poland	16	411 0.7×	246 0.8×	144 0.5×	182 1.1×	90 0.7×	73	832
Matin Sheriff United Kingdom	16	551 0.9×	364 1.2×	170 0.6×	117 0.7×	193 1.4×	33	1.0k
Cristina Rabascio Italy	17	556 1.0×	476 1.5×	243 0.9×	306 1.9×	89 0.7×	33	1.1k
Ewan Brown United Kingdom	18	501 0.9×	510 1.7×	238 0.9×	271 1.7×	132 1.0×	30	1.2k
Stephanie Petrillo Canada	18	293 0.5×	394 1.3×	216 0.8×	94 0.6×	118 0.9×	38	794
Susanna V. Ulahannan United States	17	524 0.9×	324 1.1×	168 0.6×	197 1.2×	192 1.4×	89	1.1k
Sanjeeve Balasubramaniam United States	17	454 0.8×	280 0.9×	204 0.8×	177 1.1×	149 1.1×	33	920

Countries citing papers authored by Marta Santisteban

Since Specialization

Citations

This map shows the geographic impact of Marta Santisteban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Santisteban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Santisteban more than expected).

Fields of papers citing papers by Marta Santisteban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Santisteban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Santisteban. The network helps show where Marta Santisteban may publish in the future.

Co-authorship network of co-authors of Marta Santisteban

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Santisteban. A scholar is included among the top collaborators of Marta Santisteban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Santisteban. Marta Santisteban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goñi, Enrique, Jovanna González, Amaya Abad, et al.. (2024). Uncovering functional lncRNAs by scRNA-seq with ELATUS. Nature Communications. 15(1). 9709–9709. 5 indexed citations

Perez‐Gracia, José Luis, Javier Rodríguez, Jaime Gállego Pérez‐Larraya, et al.. (2024). Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers. 16(5). 981–981. 62 indexed citations breakdown →

López‐Janeiro, Álvaro, Susana Inogés, Ascensión López-Dı́az de Cerio, et al.. (2023). Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies. Biomedicines. 11(2). 238–238. 5 indexed citations

Santisteban, Marta, Josep Lupón, José Manuel Aramendía, et al.. (2022). A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy. Cancers. 14(12). 2941–2941. 4 indexed citations

Santisteban, Marta, Luis D. Mejías, Esteban Salgado, et al.. (2021). Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis. Therapeutic Advances in Medical Oncology. 13. 4277476685–4277476685. 16 indexed citations

Sánchez-Bayona, Rodrigo, Alfredo Gea, Andrea Romanos-Nanclares, et al.. (2020). Binge Drinking and Risk of Breast Cancer: Results from the SUN (‘Seguimiento Universidad de Navarra’) Project. Nutrients. 12(3). 731–731. 9 indexed citations

González-Santiago, Santiago, Cristina Saura, Eva Ciruelos, et al.. (2020). Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study). Breast Cancer Research and Treatment. 184(2). 469–479. 15 indexed citations

Sánchez-Bayona, Rodrigo, Luis D. Mejías, A. Vilalta, et al.. (2020). 1029P Addition of dendritic cell vaccines to neoadjuvant chemotherapy in HER2 negative breast cancer patients. Annals of Oncology. 31. S710–S710. 4 indexed citations

Martín, Miguel, Ángel Guerrero‐Zotano, Á. Montero, et al.. (2020). GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain. The Oncologist. 25(9). e1339–e1345. 10 indexed citations

10.

Sánchez-Bayona, Rodrigo, Carmen Sayón-Orea, Javier Llorca, et al.. (2020). Body shape trajectories and risk of breast cancer: results from the SUN (‘Seguimiento Universidad De Navarra’) Project. Public Health Nutrition. 24(3). 467–475. 4 indexed citations

11.

Sánchez-Bayona, Rodrigo, et al.. (2020). Trastuzumab and thyroid dysfunction. Journal of Cancer Research and Therapeutics. 18(4). 1183–1185. 5 indexed citations

12.

Romano, P. Martin, Iosune Baraibar, J. Espinós, et al.. (2017). Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience. The Breast Journal. 24(4). 473–479. 9 indexed citations

13.

Mejías, Luis D., J. Espinós, P. Martin Romano, et al.. (2016). Impact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.. Journal of Clinical Oncology. 34(15_suppl). 1081–1081. 2 indexed citations

14.

García‐Velloso, María José, Macarena Rodríguez‐Fraile, Alejandro Fernández‐Montero, et al.. (2016). MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer. European Radiology. 27(8). 3190–3198. 9 indexed citations

15.

Radisky, Derek C., Marta Santisteban, Hal K. Berman, et al.. (2011). p16INK4a Expression and Breast Cancer Risk in Women with Atypical Hyperplasia. Cancer Prevention Research. 4(12). 1953–1960. 23 indexed citations

16.

Castillo, Juan C., Manuel Anguita, Martín Ruiz Ortiz, et al.. (2011). Cambios epidemiológicos de la endocarditis infecciosa sobre válvula nativa. Revista Española de Cardiología. 64(7). 594–598. 25 indexed citations

17.

Santisteban, Marta. (2010). ABC Transporters as Molecular Effectors of Pancreatic Oncogenic Pathways: The Hedgehog-GLI Model. Journal of Gastrointestinal Cancer. 41(3). 153–158. 17 indexed citations

18.

Santisteban, Marta, Jennifer M. Reiman, Michael K. Asiedu, et al.. (2009). Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells. Cancer Research. 69(7). 2887–2895. 320 indexed citations

19.

Santisteban, Marta, Jan C. Buckner, Joel M. Reid, et al.. (2008). Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results. Journal of Neuro-Oncology. 92(2). 165–175. 28 indexed citations

20.

Rodríguez, J., Emiliano Calvo, Javier Cortés, et al.. (2002). Docetaxel Plus Vinorelbine as Salvage Chemotherapy in Advanced Breast Cancer: A Phase II Study. Breast Cancer Research and Treatment. 76(1). 47–56. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact